SpringWorks Therapeutics Files 8-K on Shareholder Votes
| Field | Detail |
|---|---|
| Company | Springworks Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
Related Tickers: SWTX
TL;DR
SWTX filed an 8-K for shareholder votes on 5/14 - details to follow.
AI Summary
SpringWorks Therapeutics, Inc. filed an 8-K on May 14, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or resolutions presented, but it serves as an official notification of such events.
Why It Matters
This filing indicates that SpringWorks Therapeutics held a meeting where shareholders voted on important company matters, which could impact corporate governance and future strategic decisions.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial or operational risks.
Key Players & Entities
- SpringWorks Therapeutics, Inc. (company) — Registrant
- May 14, 2025 (date) — Date of earliest event reported
FAQ
What specific matters were submitted to a vote of SpringWorks Therapeutics' security holders?
The 8-K filing states that matters were submitted to a vote of security holders, but it does not specify what those matters were.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 14, 2025.
What is the exact name of the registrant?
The exact name of the registrant is SpringWorks Therapeutics, Inc.
What is the principal executive office address for SpringWorks Therapeutics, Inc.?
The address of the principal executive offices is 100 Washington Blvd, Stamford, CT 06902.
What is the SEC file number for SpringWorks Therapeutics, Inc.?
The SEC file number for SpringWorks Therapeutics, Inc. is 001-39044.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding SpringWorks Therapeutics, Inc..